1. Monocyte chemotactic protein 1 (MCP-1) modulates pro-survival signaling to promote progression of head and neck squamous cell carcinoma.
- Author
-
Ji WT, Chen HR, Lin CH, Lee JW, and Lee CC
- Subjects
- Adult, Aged, Carcinoma, Squamous Cell metabolism, Carcinoma, Squamous Cell mortality, Cell Survival drug effects, Chemokine CCL2 metabolism, Disease Progression, Dose-Response Relationship, Drug, Female, Head and Neck Neoplasms metabolism, Head and Neck Neoplasms mortality, Humans, MAP Kinase Signaling System drug effects, Male, Middle Aged, Proto-Oncogene Proteins c-akt metabolism, STAT3 Transcription Factor metabolism, Signal Transduction drug effects, Squamous Cell Carcinoma of Head and Neck, Survival Analysis, Tumor Cells, Cultured, Apoptosis drug effects, Carcinoma, Squamous Cell pathology, Chemokine CCL2 pharmacology, Head and Neck Neoplasms pathology
- Abstract
Background: Monocyte chemotactic protein-1 (MCP-1) recruits monocytes and macrophages to inflammation sites, and inflammatory infiltration correlates with the progression of head and neck squamous cell carcinoma (HNSCC). This study aims to determine whether MCP-1 expression is related to HNSCC malignancy and patient survival. We also investigated the relationship between MCP-1 expression and the phosphorylation state of the pro-survival pathway factors Akt, ERK, and STAT3., Methods: Expression of MCP-1 and related proteins in HNSCC cell lines was investigated using western blotting. HNSCC patients (34) without distant metastasis at diagnosis were recruited for tissue specimen evaluation of MCP-1 expression and clinical outcomes. The relationship between MCP-1 expression and survival was evaluated using the Cox proportional hazard model with stepwise selection., Results: High-grade HNSCC cell lines were found to have higher levels of active Akt, ERK, and/or STAT3 than did lower grade cell lines under serum-free condition. OCSL, the most malignant cell line, had the highest level of endogenous MCP-1. Administration of exogenous recombinant MCP-1 increased phosphorylation of Akt, ERK, and STAT3 in a dose- and time-dependent manner and increased cellular resistance to serum starvation. Inhibition of Akt, ERK, or STAT3 reduced cell growth and caused cell death. Long-term survival of HNSCC patients was negatively associated with the histological intensity of MCP-1, implicating MCP-1 as a potential prognostic marker for HNSCC., Conclusions: These results suggest that overexpressed MCP-1 in cancer cells may promote HNSCC progression through upregulating pro-survival signaling pathways. High cellular MCP-1 expression is related to poor overall survival rate in HNSCC patients.
- Published
- 2014
- Full Text
- View/download PDF